Chyluria in pregnancy: Etiology, diagnosis, and management perspective

Saudi J Kidney Dis Transpl. 2019 Mar-Apr;30(2):309-314. doi: 10.4103/1319-2442.256837.

Abstract

Chyluria is clinically described as passage of milky urine. Chyle is absorbed by intestinal lacteals and is composed of emulsified fats, few proteins, and fibrin in varying proportions. Parasitic chyluria is caused mainly by Wuchereria bancrofti infection. The incidence of chyluria in pregnancy is not uncommon in endemic regions. The literature pertaining tomedical management of chyluria in pregnancy is scant. The antifilarial drugs have potential teratogenic risk and are not recommended in pregnant patients. Hence, there is a management dilemma for managing patients with chyluria during pregnancy. In this review, we have tried to highlight the evidence-based diagnosis and management of chyluria in pregnancy.

Publication types

  • Review

MeSH terms

  • Chyle*
  • Conservative Treatment
  • Contraindications, Drug
  • Diagnosis, Differential
  • Elephantiasis, Filarial / complications
  • Elephantiasis, Filarial / diagnosis
  • Elephantiasis, Filarial / therapy*
  • Female
  • Filaricides / adverse effects
  • Filaricides / therapeutic use*
  • Humans
  • Pregnancy
  • Pregnancy Complications, Parasitic / diagnosis
  • Pregnancy Complications, Parasitic / etiology
  • Pregnancy Complications, Parasitic / therapy*
  • Sclerotherapy*
  • Urine

Substances

  • Filaricides